Abstract
The aim of this study was to estimate annual incidence rate of type 1 diabetes according to the levels of genetic susceptibility provided by HLA-DQA1 and HLA-DQB1 genotypes. Two information sources were used: (1) a population-based incidence study in which 61 incident cases were ascertained during 1 year in Santiago, Chile (incidence rate: 4.11 cases per 100,000 children per year) and (2) a case–control comparison of 57 cases (recruited from the incidence study) and 125 controls. Susceptibility alleles were defined as DQA1*0301 and DQA1*0501 for DQA1 gene and alleles DQB1*0201 and DQB1*0302 for DQB1 gene. In DQA1 gene, the highest point estimate of the incidence rate was calculated for the genotype DQA1*0501/DQA1*0501 (33.04 cases per 100,000 children aged less than 15 years old and per year; 95% CI: 9.22–118.33). In the DQB1 gene, the highest risk was estimated for the genotype DQB1*0201/DQB1*0201 (20.35 cases per 100,000 children aged less than 15 years old and per year; 95% CI: 5.26–78.67). This study shows an application on how a transformation of the logistic equation based on Bayes' theorem can be used to estimate incidence rates from case–control studies and population-based incidence rates.
This is a preview of subscription content, log in via an institution to check access.
References
Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428–1436.
Dorman JS, McCarthy B, McCanlies E, et al. and the WHO DiaMond Molecular Epidemiology Sub-Project Group. Molecular IDDM epidemiology: International studies. Diabetes Res Clin Pract 1996; 34: S107–S116.
Ronningen KS, Keiding N, Green A. Correlations between the incidence of childhood-onset type 1 diabetes in Europe and HLA genotypes. Diabetologia 2001; 44(Suppl 3): B51–B59.
Nejentsev S, Koskinen S, Sjoroos M, et al. Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. Tissue Antigens 1998; 52: 473–477.
Carrasco E, Mondragón A, Santos JL, Perez F. Incidence of type 1 diabetes mellitus under 15 years in Santiago, Chile 1993-1997. Diab Res Clin Pract 2000; 50(Suppl 1): S-120.
Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701–1710.
Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM. Diabetologia 1998; 41: 79–85.
Kupila A, Muona P, Simell T, et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001; 44: 290–297.
Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the young (DAISY). Diabetologia 1996; 39: 807–812.
Santos JL, Carrasco E, Moore AL, Pérez-Bravo F, Albala C. Incidence rate and spatio-temporal clustering of type 1 diabetes in Santiago, Chile, from 1997 to 1998. Revista de Saú de Pública 2001; 35: 96–100.
Santos JL, Pérez-Bravo F, Carrasco E, Calvillán M, Albala C. Association between HLA-DQB1 alleles and type 1 diabetes in a case-parents study conducted in Santiago, Chile. Am J Epidemiol 2001; 153: 794–798.
Pérez-Bravo F, Carrasco E, Gutierrez-Lopez MD, Martinez MT, Lopez G, de los Rios MG. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chile. J Mol Med 1996; 74: 105–109.
Santos-Martín JL, Pérez-Bravo F, Carrasco E, Albala C. Different statistical models used in the calculation of the prevalence of insulin dependent diabetes mellitus according to the polymorphisms of HLA-DQ region. Immuno Cell Biol 1997; 75: 351–355.
Perez-Bravo F, Riesco MV, Albala C, Oyarzun A, Santos JL, Carrasco E. Perfil de auto-anticuerpos y lactancia materna en pacientes diabéticos tipo 1. Rev Med Chile 2001; 129: 611–619.
Dorman JS, Bunker CH. HLA-DQ locus of the Human leukocyte antigen complex and type 1 diabetes mellitus: A Huge review. Am J Epidemiol 2000; 22: 218–227.
McCullagh P, Neider JA. Generalized Linear Models. 2nd ed., London: Chapman and Hall, 1991.
Neutra RR, Drolette ME. Estimating exposure-specific disease rates from case-control studies using Bayes' theorem. Am J Epidemiol 1978; 108: 214–222.
Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trend Genet 2001; 17: 93–100.
Ilonen J, Sjoroos M, Knip M, et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002; 115: 30–36.
Santos JL, Schaid D, Pérez-Bravo F, et al. Applicability of the case-parent design in the etiological research of type 1 diabetes in Chile and other genetically mixed populations. Diab Res Clin Pract 1999; 43: 143–146.
Cruz-Coke R. Origen y evolución étnica de la población Chilena. Rev Med Chile 1976; 104: 365–368.
Green A, Gale EAM, Patterson CC for the EURODIAB ACE Study Group. Incidence of childhoodonset insulin-dependent diabetes mellitus: The EURODIAB ACE study. Lancet 1992; 339: 905–909.
Bell J. The new genetics in clinical practice. Br Med J 1998; 316: 618–620.
Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic test in populations. The Lancet 2001; 357: 709–712.
Pietropaolo M, Becker DJ. Type 1 diabetes intervention trials. Pediatric Diab 2001; 2: 2–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Díaz, N., Méndez, M., Pérez-Bravo, F. et al. Incidence rate of type 1 diabetes in Santiago (Chile) by HLA-DQA1 and DQB1 genotypes. Eur J Epidemiol 18, 787–792 (2003). https://doi.org/10.1023/A:1025345804789
Issue Date:
DOI: https://doi.org/10.1023/A:1025345804789